Access to medicines and health products

Access to medicines and health products

 

 

Universal health coverage can only be achieved when there is affordable access to safe, effective and quality medicines and health products. 

Countries face a range of obstacles to achieving this, including rising prices for new medicines; shortages and stock outs of essential medicines, especially for noncommunicable diseases, and the growing problem of substandard and falsified medical products entering the global supply chain. Added to this, there are other challenges to ensuring that medicines are not only available, but are used appropriately. Antimicrobial resistance has become a worldwide problem largely due to overuse, and misuse of opioids has led to an addiction epidemic in some countries. Knowing where to tackle the problem is the first step. WHO works with Member States to identify what their priorities are on the road to achieving this universal access.

Areas of work

Health products policy and standards



Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.



 

Areas of work

Regulation and Prequalification



Progress towards enhancing regulatory practices related to medical products around the world is supported by capacity building, promoting regulatory convergence and harmonization.


Universal Health Coverage Day

Universal Health Coverage Day

Annually 12 December

Highlights

Publications

All →
The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use

he AWaRe classification is intended as a tool for monitoring antibiotic consumption, defining targets and monitoring the effects of stewardship policies...

The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines for Children, 10th list

Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and...

Xenotransplantation: Guidance on Infectious Disease Prevention and Management

Whether or not xenotransplantation should be done is beyond the scope of this paper. Therefore, this paper does not examine the important ethical issues...

WTO agreements and public health : a joint study by the WHO and WTO secretariat

This comprehensive document deals with the relevant WTO agreements and the way they may influence health and health policies. In undertaking this joint...